期刊文献+

术前盆腔外照射放疗与术前新辅助化疗联合手术治疗局部晚期ⅠB2~ⅡB期宫颈癌疗效对比 被引量:12

The Comparison of Efficacy between Preoperative Pelvic External Radiotherapy and Neoadjuvant Chemotherapy Followed by Surgery on Cervical Cancer of Local Advanced ⅠB2-IIB Stage
下载PDF
导出
摘要 目的探讨术前不同辅助治疗方法对局部晚期ⅠB2~ⅡB期宫颈癌的疗效。方法选择2006年1月至2009年12月农垦中心医院收治的经盆腔检查和宫颈活检病理诊断为ⅠB2~ⅡB期的宫颈癌患者85例,根据术前辅助治疗情况分为两组:A组(43例)接受术前盆腔外照射放疗,放疗结束后2~3周在腰硬联合麻醉下行宫颈癌根治术;B组(42例)接受术前新辅助化疗,化疗结束后3~4周在腰硬联合麻醉下行宫颈癌根治术。评价两组患者的近期疗效。结果 A组总有效率高于B组(79.1%vs 61.9%),差异有统计学意义(P〈0.05)。A组术中出血量、手术前后血红蛋白差值显著低于B组[(0.38±0.08)L vs(0.45±0.09)L]、[(19.49±5.45)g vs(29.91±8.67)g](P〈0.05)。A组术后盆腔淋巴转移率低于B组[(9.30%、0、30.23%、6.98%)vs(21.43%、4.76%、50%、21.43%)](P〈0.05)。A组术后1、3年复发率明显低于B组[(23.3%、48.8%)vs(38.1%、61.9%)](P〈0.05);A组3年生存率高于B组[(83.7%)vs(73.8%)](P〈0.05)。结论术前盆腔外照射放疗的疗效确切,术中出血量少,且具有更低的复发率和更高的生存率,值得临床予以推广。 Objective To explore efficacy of different methods of preoperative adjuvant therapy for locally advanced Ⅰ B2- ⅡB cervical cancer. Methods A total of 85 cases of cervical cancer patients treated by pelvic examination and cervical biopsy forⅠ B2-ⅡB period admitted to Guangdong Agribusiness Center Hospital from Jan. 2006 to Dec. 2009 were included in the study, according to the preoperative adjuvant therapy they were divided into two groups,43 cases of ⅠB2- Ⅱ B were given preoperative pelvic external radiotherapy( group A) for 2-3 weeks before the radical operation of cervical carcinoma under combined spinal epidural anesthesia;42 cases were given neoadjuvant chemotherapy (group B ) for 3-4 weeks before radical operation of cervical carcinoma under combined spinal epidural anesthesia. The short-term effect of the two groups were evaluated. Results The total effective rate of group A was higher than group B(79.1% vs 61.9% ), with statistically significant difference ( P 〈 0.05 ). Bleeding volume, hemoglobin value before and after operation of group A were lower than that in group B [ (0.38 ± 0.08 ) L vs ( 0. 45 ± 0.09 ) L ], [ ( 19.49 ± 5.45 ) g vs (29.91 ± 8.67 ) g ] ( P 〈 0. 05 ) ; postoperative pelvic lymph node metastasis rate, residual rate of vaginal, cervical deep myometrial invasion, parametrial infiltration rate of group A were lower than that of B group [ (9.30% ,0,30.23% ,6.98% ) vs(21.43% ,4.76% ,50% ,21.43% ) ] ( P 〈 0.05 ). Group A 1,3-year recurrence rate were less than B[ (23.3% ,48.8% ) vs(38.1% ,61.9% ) ] (P 〈0.05), 3-year survival rate was higher than group B[ (83.7%) vs(73.8% ) ] (P 〈0.05). Conclusion Preopera- tive pelvic external radiotherapy has exact efficacy,less intraoperative blood loss, and has a lower recurrence rate and higher survival,thus deserves promotion in clinical,
出处 《医学综述》 2014年第16期3060-3062,共3页 Medical Recapitulate
关键词 宫颈癌 术前辅助放疗 新辅助化疗 盆腔外照射 Cervical cancer Preoperative radiotherapy Neoadjuvant chemotherapy Pelvic external radio- therapy
  • 相关文献

参考文献8

二级参考文献38

  • 1宋水勤,张国楠.宫颈癌新辅助化疗现状[J].实用医院临床杂志,2005,2(2):22-25. 被引量:53
  • 2赵淑萍,王泽华.巨块型宫颈癌Ⅰ_(B2)~Ⅱ_B期68例术前全身新辅助化疗的近期疗效观察[J].中国实用妇科与产科杂志,2006,22(4):271-273. 被引量:22
  • 3Rein DT,Kurbacher CM,Breidenbach M,et al.Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer:a phase Ⅰ study[J].Gynecol Oncol,2002,87(1):98-103.
  • 4Nagata Y,Araki N,Kimura H,et al.Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer[J].J Vasc Interv Radiol,2000,11 (3):313-319.
  • 5Duenas-Gonzalez A,Lopez-Graniel C,Gonzalez A,et al.A phase Ⅱ study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma[J].Ann Oncol,2001,12(4):541-547.
  • 6Sasoka M,Fuwa N,Asuno A,et al.Patterns of failure in carcinoma of the uterine cervix treated with definitive radiotherapy alone[J].Am J Clin Oncol,2001,24(6):586-590.
  • 7Ivanov S,Zervudis S,Ivanov S.Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage Ⅰb and Ⅱa cervical cancer[J].Akush Ginekol (Sofiia),2003,42(5):22 -24.
  • 8Toita T,Mitsuhashi N,Teshima T,et al.Postoperative radiotherapy for uterine cervical cancer:results of the 1995-1997 patterns of care process survey in Japan[J].Jpn J Clin Oncol,2004,34(2):99-103.
  • 9Rosc PG.Locally advanced cervical cancer[J].Curr Opin Obstet Gynecol,2001,13 (1):65-70.
  • 10Aoki Y,Tomita M,Sato T,et al.Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix[J].Gynecol Oncol,2001,83 (2):263-267.

共引文献56

同被引文献93

  • 1刘利军.新辅助化疗加放疗治疗局部晚期宫颈癌60例临床分析[J].内蒙古医科大学学报,2012,34(S01):41-42. 被引量:1
  • 2Lingling Pan, Jingyi Cheng, Min Zhou,et al. The SU- Vmax(maximum standardized uptake value for F-18 fluo- rodeoxyglucose) and serum squamous cell carcinoma anti- gen(SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer[J]. Journal of Cancer Research and Clinical Oncology,2012, (2) : 121-122.
  • 3Gary L. Eddy, Brian N, Bundy, et al. Treatment of("bulky") stage IB cervical cancer with or without neoadjuvant vin- cristine and cisplatin prior to radical hysterecto my and pelvic/para-aortic lymphadenectomy : A phase IlI trial of the gynecologic oncology group[J]. Gynecologic Oncology, 2007, (2) :231-233.
  • 4Makoto Hirakawa, Yutaka Nagai, Morihiko Inamine, et al. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concur- rent chemoradiotherapy[J]. Gynecologic Oneology,2007, (1):758.
  • 5Shigeki Takekida, Keiichi Fujiwara,Shoji Nagao,et al. Phase H study of combination chemotherapy with docetaxel and carbo platin for locally advanced or recurrent cervical cancer[J]. International Journal of Gynecological Cancer, 2010, (9) :235.
  • 6Calzada MJ,Peso L Hypoxia-inducible factors and cancer[J]. Clinical and Translational Oncology, 2007, (5) : 331.
  • 7Muderspach L,Wilczynski S, Roman L, et al. A phase I tri- al of a human papillomavirus (HPV) peptide vaccine for Woman with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive[J]. Clinical Cancer Re- search, 2000, (3) : 121.
  • 8Tafurt-Cardona Y, Acosta-Astaiza CP, Sierra-Torres CH. The prevalence of abnomal cytology and inflammation andtheir association with risk factors for uterine cervical neo- plasms in Cauca, Colombia [J]. Rev Salud Publica (Bogota), 2012,14(1) :53-66.
  • 9刘景坡,关娟,安桂凤.27例宫颈癌术前新辅助化疗的疗效观察[J].中国肿瘤临床与康复,2010,17(1):62-63. 被引量:1
  • 10霍学青,邢建红,张玲平,詹洪晶.新辅助化疗联合放疗在局部晚期宫颈癌治疗中的作用[J].中国基层医药,2011,18(3):343-345. 被引量:19

引证文献12

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部